Clinical Trials Browser

Not yet recruiting × Hodgkin Disease × tislelizumab × Clear all

NCT06761911 2025-01-07

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Phase 4 Not yet recruiting

Hodgkin Disease, Recurrence

NCT05627115 2023-11-29

RATiFY

Phase 2 Not yet recruiting

Hodgkin Disease